Corning® Epic® System Enables Discovery of Biological Processes
News Jun 19, 2009
Corning Incorporated has announced research results using label-free Corning® Epic® technology to study new areas of cell biology, which may yield important insights for basic biological research and drug discovery applications.
According to research published recently in J Biol Chem, investigators from the University of Bonn have uncovered a new way by which receptors regulate themselves and limit the extent of their own cellular responses, thereby preventing overstimulation. This is a significant development in the current understanding of receptor biology and could help discover better therapeutic drugs.
According to Professor Evi Kostenis, Ph.D, chair, Molecular, Cellular and Pharmacobiology, Institute for Pharmaceutical Biology, University of Bonn, Germany, and senior author of the J Biol Chem study, “the novel technology is a breakthrough in both basic research and drug development. To date, it has been impossible to analyze activation of receptors and their various routes of communication with the cell interior in living cells and real time. The Epic biosensor has overcome this limitation: It captures receptor-mediated rearrangements of intracellular components and translates such rearrangements into specific optical signals. We are pleased to take advantage of this technology to both discover novel biological principles, but also to develop novel therapeutics designed to interfere with very specific cellular functions.”
“This is a great example of how label-free technology is being used to make new biological discoveries, and it underscores the future potential of the technology,” added Ron Verkleeren, business director, Corning Epic system.
Protein Target Identified That Could Prevent StrokesNews
Scientists have identified a protein, called GPR68, that senses blood flow and tells small blood vessels called arterioles when to dilate. The researchers believe medications that activate GPR68 could one day be useful to treat medical conditions, including ischemic stroke.READ MORE
Reversing an Unstoppable Cancer Cascade with ProteomicsNews
Mutations in genes that produce RAS proteins turn a normally benign process, essential for cellular growth, into a cancer stimulant that is currently undruggable. Now, cutting-edge protein analysis may help treat cancers caused by these mutations.READ MORE
The Protein and the PauparNews
Non-coding RNAs (ncRNA) exist in a limbo within cells, having been created from genes but never destined to be turned into functional protein. A ncRNA called Paupar has been shown to regulate a protein controlling brain growth, a first for these mysterious molecules.READ MORE
Comments | 0 ADD COMMENT
World Congress on Advanced Biomaterials and Tissue Engineering
Jun 20 - Jun 21, 2018